Market Research Report
Clinical Chemistry Analyzer Market by Product (Systems & Reagents), Test Type (Basic Metabolic, Electrolyte, Liver, Lipid, Renal, Thyroid Function, Specialty Chemicals), End User (Hospitals, Laboratories, Academic Research) - Global Forecast to 2019
|Published by||MarketsandMarkets||Product code||318269|
|Published||Content info||195 Pages
|Clinical Chemistry Analyzer Market by Product (Systems & Reagents), Test Type (Basic Metabolic, Electrolyte, Liver, Lipid, Renal, Thyroid Function, Specialty Chemicals), End User (Hospitals, Laboratories, Academic Research) - Global Forecast to 2019|
|Published: October 22, 2014||Content info: 195 Pages||
A combination of bottom-up and top-down approaches were used to calculate the market sizes and growth rates of the global clinical chemistry analyzers market and its subsegments. Secondary information was used to identify the overall revenues, geographic reach, and product portfolios of the market players. Estimates of their clinical chemistry analyzers segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine percentage shares of each subsegment and the relative differences in the growth rates.
The global clinical chemistry analyzers market report segments this market on the basis of products, test, end users and regions. The clinical chemistry analyzers segment is further divided into four subsegments, Small (400-800 Test/H), Medium (800-1,200 Tests/H), Large (1,200-2,000 Tests/H), and Very large (2,000 Tests/H). The reagent segment is categorized into calibrators, controls, standards and other reagents. The test segments included in this report are basic metabolic panel, electrolyte panel, liver panel, lipid profile, renal profile/kidney function panel, thyroid function panel, specialty chemical tests.
The geographic segments included in this report are Americas, Europe, BRIC, Japan and Rest of the World (RoW). The geographic analysis reveals that Americas accounted for the largest share in the global clinical chemistry analyzers market in 2014. The BRIC regional segment, on the other hand, is expected to register a faster growth from 2014 to 2019, due to the increasing demand for automation from this region.
The key drivers for this market are rise in number of lifestyle diseases; automation of laboratories will aid the growth of this market. Increasing awareness for preventative care, increase in aging population, increase in reagent rental agreements and laboratory automation will drive the demand for clinical chemistry analyzers products. Growth in the clinical chemistry market will drive the growth of the clinical chemistry analyzers market.
The report provides qualitative insights about key market shares, growth rates, and market drivers for all important subsegments. It maps the market sizes and growth rates of each subsegment and identifies the segments poised for rapid growth in each of the geographic segments. The report also includes company profiles of the market leaders. These company profiles include financial performances, product portfolios, and market developments for each company. The report also provides a competitive landscape of the clinical chemistry analyzers market. The competitive landscape covers the growth strategies adopted by the industry players over the last three years. It also includes analysis of industry developments like mergers and acquisitions, agreements and partnerships, and new product launches.
The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.
*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.